2.4 Flashcards by Rhoan Jane Altura Calunsag

Which characteristic describes antithrombin (AT)?
a. It is synthesized in megakaryocytes
b. it is activated by protein C
c. it is a cofactor of heparin
d. it is a pathological inhibitor of coagulation

c. it is a cofactor of heparin

How well did you know this?

Not at all

Perfectly

Which laboratory test is affected by heparin therapy?
A. thrombin time
B. fibrinogen assay
C. Protein C assay
D. protein S assay

A. thrombin time

How well did you know this?

Not at all

Perfectly

Abnormal APTT caused by a pathological circulating anticoagulant is:
A. Corrected with factor VIII-deficient plasma
B. Corrected with factor IX-deficient plasma
C. Corrected with normal plasma
D. Not corrected with normal plasma

D. Not corrected with normal plasma

How well did you know this?

Not at all

Perfectly

The lupus anticoagulant affects which of the following tests?
A. Factor VIII Assay
B. Factor IX Assay
C. vWF assay
D. Phospholipid-dependent assays

D. Phospholipid-dependent assays

How well did you know this?

Not at all

Perfectly

Which statements about warfarin (Coumadin) is accurate?
a. it is a vitamin B antagonist
b. It is not recommended for pregnant and lactating women
c. it needs AT as a cofactor
d. APTT test is used to monitor its dosage

b. It is not recommended for pregnant and lactating women

How well did you know this?

Not at all

Perfectly

Which statement regarding protein C is correct?
a. It is a vitamin K–independent zymogen
b. It is activated by fibrinogen
c. It activates cofactors V and VIII
d. Its activity is enhanced by protein S

d. Its activity is enhanced by protein S

How well did you know this?

Not at all

Perfectly

Which of the following is an appropriate screening test for the diagnosis of lupus anticoagulant?
a. Thrombin Time (TT)
b. russell viper venom test (RVVT)
c. D-dimer test
d. fibrinogen assay

b. russell viper venom test (RVVT)

How well did you know this?

Not at all

Perfectly

Which of the following is most commonly associated with activated protein C (APC) resistance?
a. Bleeding
b. thrombosis
c. epistaxis
d. menorrhagia

b. thrombosis

How well did you know this?

Not at all

Perfectly

A 50 year old man has been on heparin for the past 7 days. Which combination of tests is expected to be abnormal?

How well did you know this?

Not at all

Perfectly

Which of the following drugs inhibits ADP-mediated PLT aggregation?
a. Heparin
b. Warfarin
c. Aspirin
d. Prasugrel (Effient)

d. Prasugrel (Effient)

How well did you know this?

Not at all

Perfectly

Which test is used to monitor heparin therapy?
a. INR
b. Chromogenic anti-factor Xa assay
c. TT
d. PT

b. Chromogenic anti-factor Xa assay

How well did you know this?

Not at all

Perfectly

Thrombin-TM complex is necessary for activation of:
a. protein C
b. AT
c. Protein S
d. Factors V and VIII

a. protein C

How well did you know this?

Not at all

Perfectly

Which test is commonly used to monitor warfarin therapy?
a. INR
b. APTT
c. TT
d. Ecarin Time

a. INR

How well did you know this?

Not at all

Perfectly

Which clotting factors (cofactors) are inhibited by protein S?
a. Factor V and X
b. Factors Va and VIIIa
c. Factors VIII and IX
d. Factors VIII and X

b. Factors Va and VIIIa

How well did you know this?

Not at all

Perfectly

Which drug promotes fibrinolysis?
a. warfarin
b. heparin
c. urokinase
d. aspirin

c. urokinase

How well did you know this?

Not at all

Perfectly

Diagnosis of lupus anticoagulant is confirmed by which of the following criteria?
a. decreased APTT
b. correction of APTT by mixing studies
c. neutralization of the antibody by high concentration of phospholipids
d. confirmation that abnormal coagulation tests are related to factor deficiencies

c. neutralization of the antibody by high concentration of phospholipids

How well did you know this?

Not at all

Perfectly

Which of the following abnormalities is consistent with the presence of lupus anticoagulant?
a. Decreased APTT/bleeding complications
b. Prolonged APTT/thrombosis
c. Prolonged APTT/thrombocytosis
D. Thrombocytosis/thrombosis

b. Prolonged APTT/thrombosis

How well did you know this?

Not at all

Perfectly

Which of the following is a characteristic of LMWH?
a. generally requires monitoring
b. specifically acts on factor Va
c. has a longer half-life compared with unfractionated heparin (UFH)
d. can be used as a fibrinolytic agent

c. has a longer half-life compared with unfractionated heparin (UFH)

Which of the following tests is most likely to be abnormal in patients taking aspirin?
a. PLT morphology
b. PLT count
c. PLT aggrgation
d. PT

c. PLT aggrgation

Which of the following is associated with AT deficiency?
a. thrombocytosis
b. thrombosis
c. thrombocytopenia
d. bleeding

b. thrombosis

Which of the following might be associated with thrombotic events?
a. Decreased protein C
b. Increased fibrinolysis
c. Afibrinogenemia
d. Idiopathic thrombocytopenic purpura

a. Decreased protein C

Aspirin resistance may be associated with:
a. Bleeding
b. factor VIII deficiency
c. thrombosis
d. thrombocytosis

c. thrombosis

Prolonged TT is indicative of which of the following antithrombotic agents?
a. Prasugrel
b. Clopidogrel
c. Aspirin
d. Heparin

d. Heparin

Screening tests for thrombophilia should be performed on:
a. All pregnant women because of the risk of thrombosis
b. Patients with a negative family history
c. Patients with thrombotic evens occurring at a younger age
d. Patients who are receiving anticoagulant therapy

c. Patients with thrombotic evens occurring at a younger age

Prothrombin G20210A is characterized by which causes and condition? A. single mutation of prothrombin molecule/bleeding B. single mutation of prothrombin molecule/thrombosis C. Decreased levels of prothrombin/thrombosis D. Increased levels of prothrombin in plasma/bleeding

B. single mutation of prothrombin molecule/thrombosis

Factor V Leiden promotes thrombosis by preventing: A. Inactivating of factor Va B. Activation of factor V C. Activation of Protein C D. Activation of Protein S

A. Inactivating of factor Va

What is the approximate incidence of antiphospholipid antibodies in the general population? A. <1% B. 1-2% C. 3-8% D. 10-15%

B. 1-2%

Which of the following laboratory tests is helpful in the diagnosis of aspirin resistance? a. APTT b. PT c. PLT count and morphology d. PLT aggregation

d. PLT aggregation

Which of the following complications may occur as a result of decreased tissue factor pathway inhibitor (TFPI)? a. Increased episodes of hemmorage b. increased risk of thrombosis c. impaired PLT plug formation d. Immune thrombocytopenia

b. increased risk of thrombosis

Factor VIII inhibitors occur in _____ of patients with factor VIII deficiency? a. 40-50% b. 30-40% c. 25-30% d. 20-25%

d. 20-25%

Which therapy and resulting mode of action are appropriate for the treatment of a patient with a high titer of factor VII inhibitors? a. factor VIII concentrate to neutralize the antibodies b. recombinant factor VIIa to activate factor X c. factor X concentrate to activate the common PW d. FFP to replace factor VIII

b. recombinant factor VIIa to activate factor X

The Bethesda assay is used for which determination? a. Lupus anticoagulant titer b. Factor VIII inhibitor titer c. Factor V Leiden titer d. Protein S deficiency

b. Factor VIII inhibitor titer

Hyperhomocysteinemia may be a risk factor for: a. Bleeding b. thrombocythemia c. thrombosis d. thrombocytopenia

c. thrombosis

Which drug may be associated with DVT? a. Aspirin b. tPA c. Oral contraceptives d. Clopidogrel (Plavix)

c. Oral contraceptives

Argatroban may be used as an anticoagulant drug in patient with: a. DVT b. Hemorrhage c. TTP d. Thrombocytosis

a. DVT

Heparin-induced thrombocytopenia (HIT) results from: a. antibodies to heparin b. antibodies to PLTs c. antibodies to PF4 d. antibodies to heparin-PF4 complex

d. antibodies to heparin-PF4 complex

Which laboratory test is used to screen for APCR (activated protein C resistance)? a. Mixing studies with normal plasma b. mixing studies with factor deficient plasma c. modified APTT with and without APC d. Modified PT with and without APC

c. modified APTT with and without APC

Ecarin clotting time may be used to monitor: a. Heparin Therapy b. Warfarin Therapy c. Fibrinolytic Therapy d. Bivalirudin

d. Bivalirudin

Which of the following may interfere with the APCR screening test? a. lupus anticoagulant b. Protein C deficiency c. AT deficiency d. Protein S deficiency

a. lupus anticoagulant

Thrombophilia may be associated with which of the following disorders? a. afibrinogenemia b. hypofibrinogenemia c. factor VIII inhibitor d. hyperfibrinogenemia

d. hyperfibrinogenemia

Which of the following anticoagulant drugs can be used in patients with HIT? a. warfarin b. heparin c. aspirin d. argatroban

d. argatroban

Which of the following is the preferred method to monitor heparin therapy at the point of care during cardiac surgery? a. APTT b. ACT c. PT d. TT

b. ACT

Mrs. Smith has the following laboratory results,and no bleeding history: APTT: prolonged APTT results on a 1:1 mixture of the patient's plasma with normal plasma: Preincubation: prolonged APTT 2-hour incubation: prolonged APTT These results are consistent with: A. Factor VIII deficiency B. Factor VIII inhibitor C. Lupus anticoagulant D. Protein C deficiency

C. Lupus anticoagulant

Which test may be used to monitor LMWH therapy? a. APTT b. INR c. Anti-factor Xa herapin assay d. ACT

c. Anti-factor Xa herapin assay